SCHEMBL7983757

SCHEMBL7983757

Cc1cc2c(c3c4ccccc4n(C)c13)C(=O)OC2=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
MAPT P10636 2/20 0.53
CDK4 P11802 5/20 0.46
CCND1 P24385 5/20 0.46
CCNE2 O96020 2/20 0.46
CCNE1 P24864 2/20 0.46
CDK2 P24941 2/20 0.46
PRKACA P17612 2/20 0.46
PRKACG P22612 2/20 0.46
PRKACB P22694 2/20 0.46
NQO2 P16083 1/20 0.45
ALKBH5 Q6P6C2 1/20 0.43
FTO Q9C0B1 1/20 0.43
HSD17B10 Q99714 1/20 0.42
IDO1 P14902 2/20 0.42
HSP90AA1 P07900 1/20 0.42
PARP1 P09874 2/20 0.41
KDR P35968 1/20 0.40
CAMK2B Q13554 1/20 0.40
CAMK2G Q13555 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982514 0.77 GPR3 (0.46) KDM4EMAPTCDK4CCND1NQO2
SCHEMBL7971139 0.74 IDO1 (0.64) KDM4EMAPTNQO2ALKBH5FTO
SCHEMBL31634641 0.74 IDO1 (0.64) KDM4EMAPTNQO2ALKBH5FTO
SCHEMBL29376819 0.73 TERT (0.49) KDM4EMAPTCDK4CCND1CCNE2
SCHEMBL31634605 0.72 CYP1A2 (0.44) KDM4EMAPTNQO2HSD17B10PARP1
SCHEMBL26214696 0.71 KDM4E (0.64) KDM4EMAPTCDK4CCND1CCNE2
SCHEMBL8156893 0.70 KDM4E (0.41) KDM4EMAPTCDK4CCND1CCNE2
SCHEMBL21793460 0.70 KDM4E (1.00) KDM4EMAPTCDK4CCND1CCNE2
SCHEMBL8112462 0.69 GABRP (0.53) KDM4EMAPTCDK4CCND1PRKACA
SCHEMBL31634637 0.69 TTR (0.44) KDM4EMAPTHSD17B10ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300340-B1 USEFUL FOR THERAPY OF CANCER AND SOLID TUMORS ADIR ET COMPAGNIE (FR) 2001-10-09 US disclosed
US-6162822-A Bisimide compounds ADIR ET COMPAGNIE (FR) 2000-12-19 US disclosed
EP-0820985-B1 Bis imide derivatives, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 2000-08-30 EP disclosed
EP-0820985-A1 Bis imide derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1998-01-28 EP disclosed